Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
<h4>Objective</h4>To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia.<h4>Methods</h4><h4>Population</h4>adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prol...
Guardado en:
Autores principales: | Xianbin Li, Yilang Tang, Chuanyue Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cfa137a5aca45f79cbcbad31f0db9ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan SX, et al.
Publicado: (2018) -
Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
por: Somaieh Ashrafi, et al.
Publicado: (2022) -
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015) -
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
por: Izchak Kohen, et al.
Publicado: (2010)